Boston, MA, United States of America

Wei Leong Chew

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Harvard College. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Leong Chew. Retrieved from https://idiyas.com/inventor/wei-leong-chew

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Wei Leong Chew in Gene Editing

Introduction

Wei Leong Chew is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of gene editing, holding two patents that showcase his innovative work. His research focuses on RNA-guided systems, which have the potential to revolutionize genetic engineering.

Latest Patents

Wei Leong Chew's latest patents include methods for in vivo gene editing using a guide RNA and a Cas9 protein. These methods allow for the excision of exons in a target gene, resulting in the expression of a truncated polypeptide. This innovative approach has the potential to advance therapeutic strategies in genetic disorders.

Career Highlights

Wei Leong Chew is affiliated with Harvard College, where he conducts his research. His work has garnered attention for its potential applications in medicine and biotechnology. His contributions to the field of gene editing are paving the way for new treatments and therapies.

Collaborations

Some of his notable coworkers include Amy J Wagers and Mohammadsharif Tabebordbar. Their collaborative efforts contribute to the advancement of research in gene editing and related fields.

Conclusion

Wei Leong Chew's innovative work in gene editing exemplifies the potential of RNA-guided systems to transform genetic research and therapy. His contributions are significant in the ongoing quest to develop effective treatments for genetic conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…